Here’s What the FDA Label on Your Personal Care Products Means
Many consumer devices undergo the FDA clearance process, such as LED masks and fitness trackers that have features like ...
Medscape7d
Introduction to the New Prescription Drug Labeling by the Food and Drug Administration
The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for Human ...
Food Allergy Research & Education (FARE)8d
Update to FDA Guidance for Food Allergen Labeling
Changes to the FDA labeling guidance in support of FALCPA include alterations to the definitions of “major” food allergens ...
dvm36010d
Drug label is updated for pain management therapy
Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...
Great Bend Tribune1d
FDA proposes ‘Facts Up Front’ nutrition labels
The U.S. Food and Drug Administration could soon assist American consumers in reaching better health. A recent proposal from ...
The National Law Review25d
FDA Proposes Front-of-Package Labeling Requirements
You are responsible for reading, understanding, and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's Terms of Use and Privacy Policy ...
JD Supra12d
FDA Finalizes Two Food Allergen-Related Guidance Documents
FDA published two final guidance documents related to food allergens: Questions and Answers Regarding Food Allergens, ...
Managed Healthcare Executive1d
FDA Approves Expanded Label for Izervay, No Dosing Duration Limit
The updated label allows physicians to prescribe Izervay without a limitation on duration for patients with geographic ...
Fierce Pharma2d
Astellas' eye med Izervay lands key FDA label update, amping up market battle with Apellis rival
In the face of tough competition from Apellis and a recent setback with prescribers, Astellas’ geographic atrophy (GA) med ...
Medscape20d
Introduction to the New Prescription Drug Labeling by the Food and Drug Administration
Renu Lal, Pharm.D., is Scientist, Genentech, Inc.; when this article was written she was Team Leader, Division of Drug Information, Office of Training and Communications, Center for Drug ...